The International Medical Device Regulators Forum (IMDRF) has released a guidance for manufacturers on how to choose, ...

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but imperfect antibiotic candidates into more potent ones. Unlike many existing AI ...

SureNano Science is developing GEP-44 as a patented next-generation metabolic therapy designed to address the limitations of ...

New York, New York - May 13, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement outlining its ...

Faculty are voting on whether to make dramatic changes to how top undergrads are evaluated. Here’s the proposal and why it’s ...

In South Africa’s high-scrutiny digital environment, trust is becoming a defining business advantage while digital noise ...

As generative AI becomes the first stop for ideas and answers, experts question whether people are losing the habit of ...

Obexelimab marketing applications for the treatment of IgG4-RD on-target for submission to the FDA this quarter and the EMA in H2 2026 based on ...

SureNano Science is advancing GEP-44 as a next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs. The global GLP-1 market could total more ...

TELUS highlights positive results of accent-masking tech for contact centre agents, amid questions about bias, worker consent ...

OpenEvidence, an AI-powered medical search tool, has become a fast friend to America’s doctors and is now used by nearly ...